Pilgrims

Pilgrim is a private U.S. defense-biotechnology and medical device company developing battlefield-ready products for military medicine and high-risk operational environments. The company describes its mission as developing, validating, and deploying biotechnology that strengthens warfighters at the edge. Publicly described programs include Kingsfoil, a hemostatic wound dressing intended to seal wounds and promote healing; Voyager, an inhaled countermeasure for chemical threats; and ARGUS, a surveillance platform for biological and chemical hazard detection. Pilgrim appears to operate at the intersection of biotech, medical devices, biodefense, and defense health, with an emphasis on rapid translation into field-deployable products rather than a traditional therapeutic drug pipeline. Based on available public information, the company is early stage, privately held, and not a conventional pharma developer.